Actionable news
All posts from Actionable news
Actionable news in ZFGN: ZAFGEN Inc,

Zafgen Says Patient in Beloranib Study Dies

Zafgen Inc. ZFGN 22.29 % said Wednesday that a patient died during a continuing study of a rare genetic disorder that carries a high rate of mortality linked to obesity and related conditions.

The biopharmaceutical company said the cause of death is undetermined.

The announcement comes after Zafgen shares have plummeted in recent days, prompting speculation and confusion from analysts. The company didn’t say when the death occurred. A representative from the company didn’t respond to a request for comment.

Shares had dropped more than 20% in...